Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.90 -0.03 (-0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Other Non Operating Income (2024 - 2025)

Updated

Corvus Pharmaceuticals (CRVS) recorded Other Non Operating Income of -$2.01 million in Q2 2025, compared with -$1.82 million a year earlier.

Analysis

Corvus Pharmaceuticals (CRVS) Other Non Operating Income (2024 - 2025) Analysis & Trends

Starting with Q2 2024, Corvus Pharmaceuticals' Other Non Operating Income history includes 4 quarters.

  • Quarterly Other Non Operating Income has ranged from -$25.13 million in Q1 2025 to $32.85 million in Q3 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Corvus Pharmaceuticals 919.44 Mn 407.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -2.01 Mn
Mar 31, 2025 -25.13 Mn
Sep 30, 2024 32.85 Mn
Jun 30, 2024 -1.82 Mn
API Access

Corvus Pharmaceuticals Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=CRVS&period=max&api_key=YOUR_API_KEY